Cardiff Oncology (CRDF) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Cardiff Oncology (CRDF) Company Statistics | The Fly

Cardiff Oncology

· CRDF

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

91.02 M

+3.42%

General

Market Cap: $91.02M
Enterprise Value: $84.52M
Shares Outstanding: 77,800,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 100.00%
Operating Margin: -8320.08%
Net Profit Margin: -7884.06%
FCF Margin: -8054.33%
ROA: -107.29%
ROE: -103.08%
ROIC: -156.60%
Current Ratio: 3.30
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 183.58
P/FCF: —
P/B: 3.51
EV/EBITDA: -2.17

Growth

Rev 1Y: -13.18%
Rev 1Y Fwd Est: -50.73%
Rev 3Y (CAGR): 15.39%
Rev 5Y (CAGR): 10.13%
Rev 10Y (CAGR): 6.60%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $508K
Gross Margin: 100.00%
Operating Expenses: $42.77M
Operating Income: -$42.27M
Net Profit: -$40.05M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $9.2M
Working Capital: $24.8M
Total Assets: $37.33M
Net Debt: -$8.74M
Total Liabilities: $10.8M
Total Equity: $26.53M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$40.85M
Cash Flow from Investing: $36.44M
Cash Flow from Financing: $2.83M
Free Cash Flow: -$40.92M
Capital Expenditures: $62K